Glenmede Investment Management’s MaxLinear MXL Stock Holding History

Glenmede Investment Management’s Portfolio MXL Stock Details MXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$312K	Buy	+19,409	New	+$305K	﹤0.01%	1109

Other funds holding MXL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Glenmede Investment Management's MXL Position: Q3 2025 in Review

Glenmede Investment Management opened a new position in MaxLinear (MXL) in Q3 2025: 19,409 shares worth $312K. The stake represents ﹤0.01% of the portfolio and ranks #1109 among its holdings.

239 funds tracked by Wall St. Rank hold MXL as of Q3 2025.

Glenmede Investment Management held 19,409 shares of MaxLinear worth $312K as of Q3 2025.
MaxLinear was a new Glenmede Investment Management position in Q3 2025.
MaxLinear made up ﹤0.01% of Glenmede Investment Management's portfolio in Q3 2025, its #1109 holding.
239 funds tracked by Wall St. Rank held MaxLinear as of Q3 2025.

Based on Glenmede Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.